These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38323276)

  • 1. A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastoma.
    Yu X; Xu C; Zou Y; Liu W; Xie Y; Wu C
    Am J Cancer Res; 2024; 14(1):253-273. PubMed ID: 38323276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
    Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
    Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
    Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
    J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
    Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Signature of Immune Genes and Immune-Related LncRNAs in Neuroblastoma: A Study Based on GEO and TARGET Datasets.
    Zhong X; Tao Y; Chang J; Zhang Y; Zhang H; Wang L; Liu Y
    Front Oncol; 2021; 11():631546. PubMed ID: 33767996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.
    Meng X; Feng C; Fang E; Feng J; Zhao X
    J Cell Mol Med; 2020 Sep; 24(18):10367-10381. PubMed ID: 32683778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.
    Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y
    Front Immunol; 2023; 14():1135617. PubMed ID: 37081871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients.
    Yang H; Yang J; Bian H; Wang X
    Front Pediatr; 2022; 10():1049858. PubMed ID: 36568423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Potential Prognostic Genes for Neuroblastoma.
    Zhong X; Liu Y; Liu H; Zhang Y; Wang L; Zhang H
    Front Genet; 2018; 9():589. PubMed ID: 30555514
    [No Abstract]   [Full Text] [Related]  

  • 10. Ferroptosis-related gene signatures in neuroblastoma associated with prognosis.
    Chen Y; Li Z; Cao Q; Guan H; Mao L; Zhao M
    Front Cell Dev Biol; 2022; 10():871512. PubMed ID: 36147739
    [No Abstract]   [Full Text] [Related]  

  • 11. An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients.
    Wang J; Meng X; Chen K; Feng J
    Front Oncol; 2022; 12():1014845. PubMed ID: 36530992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A signature of 29 immune-related genes pairs to predict prognosis in patients with neuroblastoma.
    Song J; Zhao Q; Xu Y; Zhu L
    Int Immunopharmacol; 2020 Nov; 88():106994. PubMed ID: 33182060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of core immune-escape genes highlights TNFAIP3 as an immune-related prognostic biomarker in neuroblastoma.
    Yang L; Huang K; Cao L; Ma Y; Li S; Zhou J; Zhao Z; Wang S
    Inflamm Res; 2024 Sep; 73(9):1529-1545. PubMed ID: 39028490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma.
    Luo T; Peng J; Li Q; Zhang Y; Huang Y; Xu L; Yang G; Tan D; Zhang Q; Tan Y
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S; Zhang L; Wang H
    Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
    Tan Z; Fu S; Zuo J; Wang J; Wang H
    Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel amino acid metabolism-related gene signature to predict prognosis in clear cell renal cell carcinoma.
    Cheng X; Deng W; Zhang Z; Zeng Z; Liu Y; Zhou X; Zhang C; Wang G
    Front Genet; 2022; 13():982162. PubMed ID: 36118874
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of hub genes and their correlation with infiltration of immune cells in
    Chen J; Sun M; Chen C; Jiang B; Fang Y
    Front Immunol; 2022; 13():1016683. PubMed ID: 36311753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and application of a lactate and branched chain amino acid metabolism related gene signature in a prognosis risk model for multiple myeloma.
    Yu Z; Qiu B; Zhou H; Li L; Niu T
    Cancer Cell Int; 2023 Aug; 23(1):169. PubMed ID: 37580667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.